Latest news: Opening Maastro Clinic

Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors

The purpose of this international study is to try to predict which patients are more likely to have side effects from radiotherapy

News

Opening Maastro Clinic

18 January 2016, Maastro Clinic in Maastricht (the Netherlands) is now open to recruitment for REQUITE.

Half of target has been reached!

During Christmas or New Year the REQUITE study reached half of the recruitment target (2650 patients) and currently already has more than 2750 patients included in the study!

REQUITE Periodic Report Summary online

The first REQUITE Periodic Report Summary is now available at CORDIS, the Community Research and Development Information Service. CORDIS is the European Commission's primary public repository and portal to disseminate information on all EU-funded research projects and their results in the broadest sense.

8th Annual Radiogenomics Consortium Meeting in Maastricht!

The 8th Annual Meeting of the Radiogenomics Consortium will take place on 13 July, 2016 in Maastricht, the Netherlands and is hosted by MAASTRO-Clinic.

Older news

Recruitment

Breast
1396
Lung
306
Prostate
1262

Events

4rd Annual REQUITE meeting and 8th Annual Radiogenomics Consortium meeting

Dates: 
Monday, 11 July, 2016 to Wednesday, 13 July, 2016
Location: 
Hotel NH Maastricht 6229GV Maastricht
Netherlands
NL

ESTRO 35

ESTRO is an interdisciplinary society where radiation oncologists, medical physicists, biologists, brachytherapists and radiation therapists aspire to join forces with other organisations in the oncology field that share ESTRO’s vision of excellence in cancer treatment. http://www.estro.org/congresses-meetings/items/estro-35

Dates: 
Friday, 29 April, 2016 to Tuesday, 3 May, 2016
Location: 
Turin
Italy
IT